Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bf0d2460ebe1131608a45d8db843d01c2> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bf0d2460ebe1131608a45d8db843d01c2 NCIT_P378 "NCI" @default.
- Bf0d2460ebe1131608a45d8db843d01c2 type Axiom @default.
- Bf0d2460ebe1131608a45d8db843d01c2 annotatedProperty IAO_0000115 @default.
- Bf0d2460ebe1131608a45d8db843d01c2 annotatedSource NCIT_C200462 @default.
- Bf0d2460ebe1131608a45d8db843d01c2 annotatedTarget "An orally bioavailable, mutant-selective, third-generation epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity. Upon oral administration, EGFR mutant-selective inhibitor YK-029A targets, binds to and inhibits the activity of EGFR with exon 20 insertion (Ex20ins) activating mutations, the gatekeeper mutation T790M and some other rare mutations, thereby preventing EGFR-mediated signaling. This may both induce cell death and inhibit tumor growth in EGFR-overexpressing tumor cells. EGFR, a receptor tyrosine kinase mutated in many tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization." @default.